StockData

Codexis vs LanzaTech Global

CDXS and LNZA side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How CDXS and LNZA compare

Codexis is the larger company, worth 3.2 times as much as LanzaTech Global ($116M against $36.8M).

LanzaTech Global grew revenue faster over the last twelve months (43.8% versus 35.9% for Codexis).

LanzaTech Global keeps more of each dollar of sales as profit, with a net margin of 296% compared with −39.6% at Codexis.

LanzaTech Global scores higher on the StockData Score (12 against 5 for Codexis), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricCDXSLNZA
Size and price
Market cap$116M$36.8M
Share price$1.06$2.81
Change, 1 year−35.0%−83.7%
Change, 5 years−97.1%−99.7%
Beta (5Y)2.47−0.26
Employees146192
StockData Score
Total score512 (better)
Valuation score12 (better)
Growth score22
Performance score13 (better)
Health score15 (better)
Dividend score00
Valuation
P/E–0.2×
P/S1.5×0.6× (better)
P/B3.5×0.1× (better)
FCF yield−10.5% (better)−91.9%
Fair value$1.07–
Margin of safety0.79%–
Growth
Revenue growth (TTM)35.9%43.8% (better)
Revenue growth, 5Y average0.38%–
Profitability
Gross margin87.0%–
Operating margin−35.6% (better)−61.0%
Net margin−39.6%296% (better)
FCF margin−15.7% (better)−58.0%
Return on equity−69.4%146% (better)
Return on invested capital−91.8%−37.2% (better)
Financial health
Debt / equity1.24 (better)0.00
Current ratio3.06 (better)2.48
Altman Z-score−6.15−3.36 (better)
Piotroski F-score4 (better)3
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions63.7%25.4%
Held by insiders2.2%–
Insider net buying, 12 months−$899K$4.3M (better)
Short interest, % of float4.1%–

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.